Nanostructured Drug Market Enhancement and Growth Rate Analysis 2026
Nanotechnology
is an emerging field of science that involves atomic or molecular
level manipulation of matter. A nanometer is equals to 1 billionth of
a meter. Nanotechnology has various application in different fields
such as chemical sensors, batteries, food, fuel cells, solar cells,
fabric, fuels, electronics, space, better air quality, cleaner water,
and sporting goods. One of the key application of nanotechnology is
in medicine, nano-medicine ranges from the medical application such
as biological device, nanomaterial, nanoelectronic biosensors, and
biological machines. Nanotechnology has presented the option of drug
delivery to specific target cells employing nanoparticles. Particles
are engineered to attach to diseases cells, which allows of direct
treatment of those cells. Drug delivery techniques are designed to
reduce the side effects associated with the drugs along with decrease
in its consumption and treatment costs. Nanostructured drugs have
various applications such as in neurology, cardiovascular/physiology,
anti-inflammatory/immunology, anti-infective, and others.
Nanostructured Drug Market – Regional
Insights
Based on the region, the
global nanostructured drug treatment market is segmented into North
America, Latin America, Europe, Asia Pacific, Middle East, and
Africa. North America holds the dominant position in the global
nanostructured drug market, owing to massive funding by the
government for the nanotechnology research. For instance, According
to a study led by Lux Research with funding support from U.S.
national Foundation and U.S. National Nanotechnology Coordination
Office in 2013, around US$ 1.9 billion was funded in 2011 and US$ 2.1
billion in 2012 for nanotechnology research and development (R&D).
Moreover, increasing awareness among the population regarding various
chronic diseases and well established healthcare infrastructure is
expected to propel the nanostructured drug market growth over the
forecast period.
Asia pacific is expected to gain significant
market share in the nanostructured drug market, followed by Europe,
owing to increasing number of population susceptible to various
chronic diseases such cancer, HIV, and tuberculosis. For instance,
according to the National Health and Family Planning Commission of
the PRC report in 2015, around 533 out of 100,000 people died from
chronic disease in 2012 in China, accounting for 86.6% of all deaths.
Nanostructured Drug Market – Regional
Landscape
The key players operating in the global
nanostructured drug market include Nanoviricides Inc., Ablynx NV,
Pfizer Inc., Nanotherapeutics Inc., Arrowhead Research Inc., Abraxis
Inc., Merck, Bio-Gate AG, and Celgene Corporation.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/1841
Nanostructured Drug Market Taxonomy
On the basis of technology, the global
nanostructured drug market is segmented into:
-
Nanoparticles
-
Nanocrystals
-
Nanotubes
-
Liposomes
-
Micelles
-
Others
On the basis of application, the global
nanostructured drug market is segmented into:
-
Neurology
-
Oncology
-
Cardiovascular/Physiology
-
Anti-inflammatory/Immunology
-
Anti-infective
-
Others
On the basis of geography, the global
nanostructured drug market is segmented into:
-
North America
-
Latin America
-
Europe
-
Asia Pacific
-
Middle East
-
Africa
About
Coherent Market Insights
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us
Mr.
Shah
Coherent
Market Insights
1001
4th Ave, #3200
Seattle,
WA 98154
Tel:
+1-206-701-6702

Comments
Post a Comment